Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,310
archived clinical trials in
Allergy

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  2/6/2018
GSK Investigational Site
mi
from
Kerrville, TX
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 2/6/2018
GSK Investigational Site
mi
from
Kerrville, TX
Click here to add this to my saved trials
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  2/6/2018
GSK Investigational Site
mi
from
New Braunfels, TX
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 2/6/2018
GSK Investigational Site
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  2/6/2018
GSK Investigational Site
mi
from
San Antonio, TX
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 2/6/2018
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Stanford University
mi
from
Stanford, CA
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Lurie Children's Hospital
mi
from
Chicago, IL
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Division of Immunology, Children's Hospital Boston
mi
from
Boston, MA
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Division of Immunology, Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated:  2/20/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Enrolling
Updated: 2/20/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oral Immunotherapy (OIT) for Peanut Allergy
Oral Immunotherapy for Peanut Allergy- Peanut Oral Immunotherapy (PnOIT3)
Status: Enrolling
Updated:  2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Oral Immunotherapy (OIT) for Peanut Allergy
Oral Immunotherapy for Peanut Allergy- Peanut Oral Immunotherapy (PnOIT3)
Status: Enrolling
Updated: 2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
Status: Enrolling
Updated:  2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
Status: Enrolling
Updated: 2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
Peanut OIT & Anti-IgE: Peanut Oral Immunotherapy and Anti-IgE Treatment for Peanut Allergy {NIH R21 Combined Peanut Oral Immunotherapy and Anti-IgE: Mechanistic Studies}
Status: Enrolling
Updated:  2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
Peanut OIT & Anti-IgE: Peanut Oral Immunotherapy and Anti-IgE Treatment for Peanut Allergy {NIH R21 Combined Peanut Oral Immunotherapy and Anti-IgE: Mechanistic Studies}
Status: Enrolling
Updated: 2/27/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 404
mi
from
Phoenix, AZ
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 404
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 412
mi
from
Gainesville, FL
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 412
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 368
mi
from
Tampa, FL
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 368
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 03
mi
from
Lincoln, NE
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 03
mi
from
Lincoln, NE
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 16024
mi
from
Winston-Salem, NC
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 16024
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 413
mi
from
Seattle, WA
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 413
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated:  2/27/2018
Study Site 402
mi
from
Washington,
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status: Enrolling
Updated: 2/27/2018
Study Site 402
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
A Single-Center, Randomized, Double-Masked, Vehicle and Active-Controlled, Dose-Ranging Phase 2 Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model (Ora-CAC®)
Status: Enrolling
Updated:  2/28/2018
Andover Eye Associates
mi
from
Andover, MA
Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
A Single-Center, Randomized, Double-Masked, Vehicle and Active-Controlled, Dose-Ranging Phase 2 Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model (Ora-CAC®)
Status: Enrolling
Updated: 2/28/2018
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
Oxidant Stress and Allergic Asthma
Status: Enrolling
Updated:  3/2/2018
Dep. of Medicine, Div. of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University
mi
from
Nashville, TN
Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
Oxidant Stress and Allergic Asthma
Status: Enrolling
Updated: 3/2/2018
Dep. of Medicine, Div. of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Status: Enrolling
Updated:  3/2/2018
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Status: Enrolling
Updated: 3/2/2018
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Status: Enrolling
Updated:  3/2/2018
Comprehensive Lung Center - Falk Clinic
mi
from
Pittsburgh, PA
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Status: Enrolling
Updated: 3/2/2018
Comprehensive Lung Center - Falk Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Beverly Hills, CA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Huntington Beach, CA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Mission Viejo, CA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
San Diego, CA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Santa Barbara, CA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Colorado Springs, CO
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Englewood, CO
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Englewood, CO
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Fort Collins, CO
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Woodstock, GA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Woodstock, GA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Chicago, IL
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Evansville, IN
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Louisville, KY
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Covington, LA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Covington, LA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Shreveport, LA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Bangor, ME
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Bangor, ME
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Baltimore, MD
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Rockville, MD
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Novi, MI
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Novi, MI
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Ypsilanti, MI
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Minneapolis, MN
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Mount Laurel, NJ
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Mount Laurel, NJ
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Liverpool, NY
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Liverpool, NY
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Rochester, NY
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Canton, OH
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Cincinnati, OH
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
North Olmsted, OH
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
North Olmsted, OH
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Lake Oswego, OR
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Portland, OR
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated:  3/7/2018
GSK Investigational Site
mi
from
Easton, PA
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Status: Enrolling
Updated: 3/7/2018
GSK Investigational Site
mi
from
Easton, PA
Click here to add this to my saved trials